Microbiota-induced lipid peroxidation impairs obeticholic acid-mediated antifibrotic effect towards nonalcoholic steatohepatitis in mice

Obeticholic acid (OCA) has been examined to treat non-alcoholic steatohepatitis (NASH), but has unsatisfactory antifibrotic effect and deficient responsive rate in recent phase III clinical trial. Using a prolonged western diet-feeding murine NASH model, we show that OCA-shaped gut microbiota induce...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhuge, Aoxiang, Li, Shengjie, Yuan, Yin, Han, Shengyi, Xia, Jiafeng, Wang, Qiangqiang, Wang, Shuting, Lou, Pengcheng, Li, Bo, Li, Lanjuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830314/
https://www.ncbi.nlm.nih.gov/pubmed/36584600
http://dx.doi.org/10.1016/j.redox.2022.102582

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830314/
https://www.ncbi.nlm.nih.gov/pubmed/36584600
http://dx.doi.org/10.1016/j.redox.2022.102582

Ejemplares similares